The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populations.

Harry P Selker Dorothy DulkoDavid J GreenblattMarisha E PalmLudovic Trinquart

Published in: Journal of clinical and translational science (2023)

To fulfill this potential, we believe N-of-1 trials should be built into our current healthcare ecosystem. To this end, we are building the needed infrastructure and engaging the stakeholders who should receive value from this approach.

Keyphrases

healthcare
human health
climate change
risk assessment
combination therapy
social media